Cargando…
Should Cystatin C eGFR Become Routine Clinical Practice?
Kidney function assessment is crucial for diagnosing and managing kidney diseases. Glomerular filtration rate (GFR) is widely used as an indicator of kidney function, but its direct measurement is challenging. Serum creatinine, a commonly used marker for estimating GFR (eGFR), has limitations in acc...
Autores principales: | Spencer, Sebastian, Desborough, Robert, Bhandari, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377068/ https://www.ncbi.nlm.nih.gov/pubmed/37509111 http://dx.doi.org/10.3390/biom13071075 |
Ejemplares similares
-
Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012) -
Potential relationship between eGFR(cystatin C)/eGFR(creatinine)‐ratio and glomerular basement membrane thickness in diabetic kidney disease
por: Öberg, Carl M., et al.
Publicado: (2021) -
Clinical Assessment of Follow-Up Cystatin C-Based eGFR in Live Kidney Donors
por: Han, Hyun Ho, et al.
Publicado: (2012) -
eGFR(cystatinC)/eGFR(creatinine) ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study
por: Avotins, Lauris, et al.
Publicado: (2023) -
Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia
por: Suzuki, Keita, et al.
Publicado: (2022)